Hypoxia-inducible factor-1 in tumour angiogenesis

Area of Science:

• Molecular Biology
• Cellular Biology
• Oncology

Background:

• Hypoxia-inducible factor-1 (HIF-1) is a key transcriptional activator.
• HIF-1, composed of HIF-alpha and HIF-beta subunits, plays a critical role in cellular response to hypoxia.
• HIF-1alpha activation is implicated in angiogenesis, metabolic adaptation, and cell survival.

Purpose of the Study:

• To review the structure and function of HIF-1alpha.
• To summarize the regulators and signaling pathways involved in HIF-1 regulation.
• To explore the correlation between HIF-1 activation and tumor progression.

Main Methods:

• Literature review of studies on HIF-1 structure, function, and regulation.
• Analysis of identified HIF-1 target genes and hypoxia-response elements.
• Examination of signaling pathways and regulators affecting HIF-1.

Main Results:

• HIF-1alpha is overexpressed and activated under hypoxic conditions, growth factor stimulation, and oncogene/carcinogen activation.
• Dozens of direct HIF-1 target genes have been identified via hypoxia-response elements.
• HIF-1 activation, coupled with specific signaling pathways and regulators, is linked to tumor progression and prognosis.

Conclusions:

• HIF-1 is essential for physiological and pathological processes, particularly in low-oxygen environments.
• Understanding HIF-1 regulation by various stimuli and pathways is crucial for its role in disease.
• HIF-1 activation is a significant factor in cancer development and patient outcomes.